Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Martek Biosciences Corp. - Zacks Elite Stock of the Day
Sep 16, 2008 08:52 AM
- Martek reports surge in Q3 income, expects strong Q4 sales
Sep 05, 2008 03:11 AM
- Profiting From the Mini-Baby Boom
Aug 24, 2008 11:30 PM
- Martek Bioseciences: Nutritional Value
Jun 09, 2008 10:01 AM
- Notable Earnings for the Week - 06/02 - 06/06
Jun 02, 2008 10:13 AM
- Martek to Announce Second Quarter 2008 Results on June 4, 2008 and Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
May 22, 2008 11:59 AM
- Cytokinetics Announces Addition to Board of Directors and Martek Announces Addition to Its Board of Directors
May 19, 2008 08:59 AM
- Cytokinetics Announces Addition to Board of Directors and Martek Announces Addition to Its Board of Directors
May 19, 2008 08:59 AM
- NASDAQ Technical Picture - Lowest Close Since Oct. 2006
Mar 07, 2008 10:05 AM
- A Lot More Noise
Mar 06, 2008 10:06 AM
- Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
Dec 02, 2008 09:01 AM
- Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
Dec 01, 2008 12:38 PM
- Martek Marks Major Milestones: 100th Product Launched Featuring life'sDHA(TM); 15 Years on the NASDAQ
Nov 18, 2008 09:05 AM
- Martek Biosciences Corporation (MATK) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
Nov 17, 2008 04:13 PM
- Martek to Present at Upcoming Canaccord Adams Conference
Oct 08, 2008 03:30 PM
- Martek's life'sDHA(TM) Featured in New Live Bright(TM) Brain Health Bar from Kellogg
Oct 01, 2008 03:45 PM
- Keep Brain Health Top of Mind With New Live Bright(TM) Brain-Health Bars
Oct 01, 2008 09:25 AM
- Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap
Sep 24, 2008 11:30 AM
- Martek is Now the Sole-Source Supplier of ARA for all Infant Formula Products Manufactured by Hochdorf Nutricare
Sep 22, 2008 04:00 PM
- Martek to Present at Upcoming UBS Conference
Sep 18, 2008 05:00 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MATK
|
Compare to S&P
|
| YTD |
-5.71 %
|
-0.01 %
|
| 4 Weeks |
-10.78 %
|
5.72 %
|
| 12 Weeks |
-15.87 %
|
21.37 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 47.37 %
|
|
Sales Growth in Last Quarter: -2.56 %
|
|
Sales Growth in Last Quarter: 13.56 %
|
|
|
